NCT03471819 is a clinical trial of Serum serotonin level in Dermatologic Disease, sponsored by Assiut University.

Who is sponsoring NCT03471819?

NCT03471819 is sponsored by Assiut University.

What drugs are being tested in NCT03471819?

Interventions in NCT03471819: Serum serotonin level.

What condition does NCT03471819 study?

NCT03471819 studies Dermatologic Disease.

Is NCT03471819 still recruiting?

NCT03471819 is currently status unknown. Last updated 22 March 2018.

Last reviewed 2018-03-22 · How we verify

NCT03471819

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Serotonin Levels in Atopic Dermatitis Patients

Status unknown Last updated 22 March 2018

What this trial tests

trial testing Serum serotonin level in Dermatologic Disease in 50 participants. Status unknown.

Timeline

1 April 2018

Primary endpoint
31 March 2019

30 April 2019

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 April 2018
Primary completion	31 March 2019
Estimated completion	30 April 2019

Drugs / interventions tested

Serum serotonin level

Conditions studied

Dermatologic Disease — all drugs for Dermatologic Disease →

Sponsor

Assiut University

Who can join

2 and older, any sex, with Dermatologic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Atopic dermatitis (AD) is a chronic pruritic inflammatory skin disease of unknown aetiology. Global prevalence rates range from 1%-20%.AD is often worsened by stress and anxiety.Plasma levels of 5-HT were found to be positively correlated with the disease severity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dermatologic Disease

Currently open trials in the same condition.

NCT05898308 — Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus · Phase 4 · recruiting
NCT06485050 — Photodynamic Therapy and Topical Antifungal for Onychomycosis in Patients With Diabetes. · NA · active not recruiting
NCT05621369 — Psorcast Mobile Study · recruiting
NCT03848962 — Collection and Distribution of Biospecimens for Novel Research Uses · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03471819 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 22 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03471819.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing